Mariner, LLC
- SEC CIK
- 0001373442
- Latest filing
- Aug 13, 2026
SGMOQ holding history
Sangamo Therapeutics, Inc in every 13F filed by Mariner, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SGMOQ overviewAll 13F holders of SGMOQFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −56,732−100.0% | Sold out | Holders |
| Q4 2025 | 56,732 | $23.8K | <0.1% | −4,050−6.7% | Reduced | Holders |
| Q3 2025 | 60,782 | $40.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 60,782 | $32.9K | <0.1% | +60,782 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −16,437−100.0% | Sold out | Holders |
| Q3 2023 | 16,437 | $9.86K | <0.1% | +16,437 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −13,716−100.0% | Sold out | Holders |
| Q1 2023 | 13,716 | $24.0K | <0.1% | −1,614−10.5% | Reduced | Holders |
| Q4 2022 | 15,330 | $48.0K | <0.1% | −577−3.6% | Reduced | Holders |
| Q3 2022 | 15,907 | $78.0K | <0.1% | +15,907 | New | Holders |